KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) has announced robust financial results for the third quarter of 2024, ...

JMP Securities raised the firm’s price target on Vertex (VERX) to $61 from $47 and keeps an Outperform rating on the shares. The company ...

Vertex, Inc. VERX reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance on ...

Stay informed and make strategic decisions with our Ratings Table. Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with ...

Vertex, Inc. ( (VERX) ) has released its Q3 earnings. Here is a breakdown of the information Vertex, Inc. presented to its investors. Vertex, ...

Vertex's growth momentum remains strong, supported by ECC to S/4HANA migration and multi-year ERP upgrade cycle. Read my ...

Fintel reports that on November 4, 2024, Jefferies upgraded their outlook for Vertex (NasdaqGM:VERX) from Hold to Buy.

Latest release includes Pega GenAI enhancements and increased flexibility to accelerate transformation, improve customer and employee experiences, and maximize efficiency CAMBRIDGE, Mass. – October 29 ...

Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

Vertex has reported phase 3 data on its near-approval pain drug candidate suzetrigine, shedding light on how the non-opioid painkiller combines with ibuprofen and why the prospect failed to match ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As of , had a $0.0 market capitalization, putting it in the percentile of companies in the industry. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. ’s ...